<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03087149</url>
  </required_header>
  <id_info>
    <org_study_id>VitD-2016</org_study_id>
    <nct_id>NCT03087149</nct_id>
  </id_info>
  <brief_title>Monitored vs Standard Supplementation of Vitamin D in Preterm Infants</brief_title>
  <acronym>MOSVID</acronym>
  <official_title>Supplementation of Vitamin D in Preterm Infants- Monitored Therapy vs Standard Therapy. A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Princess Anna Mazowiecka Hospital, Warsaw, Poland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medical University of Warsaw</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Princess Anna Mazowiecka Hospital, Warsaw, Poland</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine wheather the monitored vitamin D (vit D) therapy is
      safer and more effective than standard therapy in pretrem infants.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Vitamin D (vit D) deficiency is a risk factor of osteopenia of prematurity, which leads to
      rickets or decreased bone mass mineral density. Recently multiple studies have been published
      on vit D adjust biological functions. Dosage, safety and effectiveness of vitD
      supplementation in preterm infants still remains a controversial topic. We hypothesize that
      monitored supplementation of vit D is more effective and safer than standard therapy 500IU in
      preterm infants. The study will be carried out in 138 preterm infants, born at 24-32 week of
      gestational age (GA) at the Princess Anne's Hospital in Warsaw, Poland. We will determine if
      monitored supplementation of vit D decreases the incidence of vit D deficiency and/or
      overdosing at 40 week (GA). For secondary objective we shall assess if monitored therapy
      reduces the incidence of vit D deficiency and/or overdosing at 35, 52 week (GA), prevalence
      of osteopenia, low bone mass, nephrocalcinosis and nephrolithiasis.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2017</start_date>
  <completion_date type="Anticipated">December 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">May 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>vitamin D- normal range</measure>
    <time_frame>at 40 (+/-2 weeks) PMA (postmenstrual age)</time_frame>
    <description>25-hydroxyvitamin D serum level between 20ng/ml (50nmol/l ) and 100ng/ml (250nmol/l ) (normal level) and between 25-hydroxyvitamin D serum level between 30-50ng/ml (75-125nmol)- optimal level</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>biochemical markers of osteopenia</measure>
    <time_frame>at 35, 40, 52 (+/-2 weeks) PMA (postmenstrual age)</time_frame>
    <description>ALP&gt;500IU and serum phosphate level &lt;1,8mmol/l</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>average of bone mass</measure>
    <time_frame>at 35, 40 (+/-2 weeks) PMA</time_frame>
    <description>measurement of speed of sound [SOS] in meters per second in the axial transmission mode with a small ultrasound probe along the mid tibia by Sunlight Omnisence 7000 Premier using CRB Probe</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hypercalcemia</measure>
    <time_frame>at 35, 40, 52 (+/-2 weeks) PMA (postmenstrual age)</time_frame>
    <description>serum calcium level above 2,75mmol/l</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hypercalcuria</measure>
    <time_frame>at 35, 40, 52 (+/-2 weeks) PMA</time_frame>
    <description>urine calcium:creatinine ratio &gt;3,8mmol/mmol for 0-4 week of age; &gt;3,5mmol/mmol for 5-8 week of age; &gt;2,8mmol/mmol for 9-12 week of age; &gt;2,5mmol/mmol for 13-18 week of age; &gt;2,2mmol/mmol for &gt;19 week of age</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>nephrocalcinosis</measure>
    <time_frame>at 35, 52 (+/-2 weeks) PMA</time_frame>
    <description>nephrocalcinosis detected in ultrasonography examination of kidneys</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>vitamin D- optimal range</measure>
    <time_frame>at 35, 40, 52 (+/-2 weeks) PMA (postmenstrual age)</time_frame>
    <description>25-hydroxyvitamin D serum level between 30ng/ml (75nmol/l ) and 50ng/ml (125nmol/l )</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>vitamin D- normal range</measure>
    <time_frame>at 35, 52 (+/-2 weeks) PMA (postmenstrual age)</time_frame>
    <description>ALP&gt;500IU and serum phosphate level &lt;1,8mmol/l</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">138</enrollment>
  <condition>Vitamin D Deficiency</condition>
  <condition>Osteopenia</condition>
  <condition>Nephrolithiasis</condition>
  <condition>Drug Overdose</condition>
  <arm_group>
    <arm_group_label>monitored group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The monitored group will received monitored vit D supplementation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>standard group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The standard group will receive standard vit D supplementation</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>monitored vit D supplementation</intervention_name>
    <description>The vit D supplementation dose start from dose 500IU from 7th day of age and is modified based on vit D measurement at 4 week of age for infants born &lt;30 GA, at 8 week of age for infants born &lt;26 GA at 35+/-2 weeks PMA(postmenstrual age), +/-at 40+/-2 weeks PMA according to the protocol.</description>
    <arm_group_label>monitored group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>standard vit D supplementation</intervention_name>
    <description>The vitamin D supplementation dose is 500IU from 7th day of age.</description>
    <arm_group_label>standard group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Preterm infants born between 24 and 32 weeks of gestation (estimated by ultrasound)

          -  In born or admitted to the unit within 48hours from birth.

          -  Randomization within 7 days from birth.

          -  Parental consent.

          -  Mothers willing to return for follow up visits.

        Exclusion Criteria:

          -  Preterm delivery &gt;=33 weeks of gestation or term delivery (estimated by ultrasound).

          -  Major congenital abnormalities.

          -  Participation in another trial.

          -  Severe illness at birth deemed incompatible with survival.

          -  Congenital HIV infection.

          -  Total parenteral nutrition &gt; 14 days.

          -  Cholestasis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>7 Days</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maria K Borszewska-Kornacka, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>Princess Anna Mazowiecka Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alicja J Kołodziejczyk</last_name>
    <phone>501049246</phone>
    <phone_ext>+48</phone_ext>
    <email>zuzialicja@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Joanna S Seliga-Siwecka, Doctor</last_name>
    <phone>502053351</phone>
    <phone_ext>+48</phone_ext>
    <email>seliga.joanna@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Princess Anna Mazowiecka Hospital</name>
      <address>
        <city>Warsaw</city>
        <zip>00-315</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria K Borszewska-Kornacka, Professor</last_name>
      <phone>225966155</phone>
      <phone_ext>+48</phone_ext>
      <email>mariak@szpitalkarowa.pl</email>
    </contact>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <link>
    <url>http://www.yeec.com/uploadimages1/forum/kone/konelabreferencemanual.pdf</url>
  </link>
  <link>
    <url>http://www.ilexmedical.com/files/download/1382861508z08Qo.pdf</url>
  </link>
  <reference>
    <citation>Backström MC, Mäki R, Kuusela AL, Sievänen H, Koivisto AM, Ikonen RS, Kouri T, Mäki M. Randomised controlled trial of vitamin D supplementation on bone density and biochemical indices in preterm infants. Arch Dis Child Fetal Neonatal Ed. 1999 May;80(3):F161-6.</citation>
    <PMID>10212074</PMID>
  </reference>
  <reference>
    <citation>Rigo J, Pieltain C, Salle B, Senterre J. Enteral calcium, phosphate and vitamin D requirements and bone mineralization in preterm infants. Acta Paediatr. 2007 Jul;96(7):969-74. Review.</citation>
    <PMID>17577338</PMID>
  </reference>
  <reference>
    <citation>Zerofsky M, Ryder M, Bhatia S, Stephensen CB, King J, Fung EB. Effects of early vitamin D deficiency rickets on bone and dental health, growth and immunity. Matern Child Nutr. 2016 Oct;12(4):898-907. doi: 10.1111/mcn.12187. Epub 2015 Apr 7.</citation>
    <PMID>25850574</PMID>
  </reference>
  <reference>
    <citation>Zhu K, Whitehouse AJ, Hart PH, Kusel M, Mountain J, Lye S, Pennell C, Walsh JP. Maternal vitamin D status during pregnancy and bone mass in offspring at 20 years of age: a prospective cohort study. J Bone Miner Res. 2014;29(5):1088-95. doi: 10.1002/jbmr.2138.</citation>
    <PMID>24189972</PMID>
  </reference>
  <reference>
    <citation>Dinlen N, Zenciroglu A, Beken S, Dursun A, Dilli D, Okumus N. Association of vitamin D deficiency with acute lower respiratory tract infections in newborns. J Matern Fetal Neonatal Med. 2016 Mar;29(6):928-32. doi: 10.3109/14767058.2015.1023710. Epub 2015 Mar 19.</citation>
    <PMID>25786473</PMID>
  </reference>
  <reference>
    <citation>Grant CC, Kaur S, Waymouth E, Mitchell EA, Scragg R, Ekeroma A, Stewart A, Crane J, Trenholme A, Camargo CA Jr. Reduced primary care respiratory infection visits following pregnancy and infancy vitamin D supplementation: a randomised controlled trial. Acta Paediatr. 2015 Apr;104(4):396-404. doi: 10.1111/apa.12819. Epub 2014 Oct 21.</citation>
    <PMID>25283480</PMID>
  </reference>
  <reference>
    <citation>Gernand AD, Simhan HN, Caritis S, Bodnar LM. Maternal vitamin D status and small-for-gestational-age offspring in women at high risk for preeclampsia. Obstet Gynecol. 2014 Jan;123(1):40-8. doi: 10.1097/AOG.0000000000000049.</citation>
    <PMID>24463662</PMID>
  </reference>
  <reference>
    <citation>Whitehouse AJ, Holt BJ, Serralha M, Holt PG, Kusel MM, Hart PH. Maternal serum vitamin D levels during pregnancy and offspring neurocognitive development. Pediatrics. 2012 Mar;129(3):485-93. doi: 10.1542/peds.2011-2644. Epub 2012 Feb 13.</citation>
    <PMID>22331333</PMID>
  </reference>
  <reference>
    <citation>Pludowski P, Holick MF, Pilz S, Wagner CL, Hollis BW, Grant WB, Shoenfeld Y, Lerchbaum E, Llewellyn DJ, Kienreich K, Soni M. Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-a review of recent evidence. Autoimmun Rev. 2013 Aug;12(10):976-89. doi: 10.1016/j.autrev.2013.02.004. Epub 2013 Mar 28. Review.</citation>
    <PMID>23542507</PMID>
  </reference>
  <reference>
    <citation>Vogiatzi MG, Jacobson-Dickman E, DeBoer MD; Drugs, and Therapeutics Committee of The Pediatric Endocrine Society. Vitamin D supplementation and risk of toxicity in pediatrics: a review of current literature. J Clin Endocrinol Metab. 2014 Apr;99(4):1132-41. doi: 10.1210/jc.2013-3655. Epub 2014 Jan 23. Review.</citation>
    <PMID>24456284</PMID>
  </reference>
  <reference>
    <citation>Javaid MK, Crozier SR, Harvey NC, Gale CR, Dennison EM, Boucher BJ, Arden NK, Godfrey KM, Cooper C; Princess Anne Hospital Study Group. Maternal vitamin D status during pregnancy and childhood bone mass at age 9 years: a longitudinal study. Lancet. 2006 Jan 7;367(9504):36-43. Erratum in: Lancet. 2006 May 6;367(9521):1486.</citation>
    <PMID>16399151</PMID>
  </reference>
  <reference>
    <citation>Hollis BW, Johnson D, Hulsey TC, Ebeling M, Wagner CL. Vitamin D supplementation during pregnancy: double-blind, randomized clinical trial of safety and effectiveness. J Bone Miner Res. 2011 Oct;26(10):2341-57. doi: 10.1002/jbmr.463. Erratum in: J Bone Miner Res. 2011 Dec; 26(12):3001.</citation>
    <PMID>21706518</PMID>
  </reference>
  <reference>
    <citation>Whitehouse AJ, Holt BJ, Serralha M, Holt PG, Hart PH, Kusel MM. Maternal vitamin D levels and the autism phenotype among offspring. J Autism Dev Disord. 2013 Jul;43(7):1495-504. doi: 10.1007/s10803-012-1676-8.</citation>
    <PMID>23070790</PMID>
  </reference>
  <reference>
    <citation>Çetinkaya M, Çekmez F, Erener-Ercan T, Buyukkale G, Demirhan A, Aydemir G, Aydin FN. Maternal/neonatal vitamin D deficiency: a risk factor for bronchopulmonary dysplasia in preterms? J Perinatol. 2015 Oct;35(10):813-7. doi: 10.1038/jp.2015.88. Epub 2015 Jul 30.</citation>
    <PMID>26226242</PMID>
  </reference>
  <reference>
    <citation>Cizmeci MN, Kanburoglu MK, Akelma AZ, Ayyildiz A, Kutukoglu I, Malli DD, Tatli MM. Cord-blood 25-hydroxyvitamin D levels and risk of early-onset neonatal sepsis: a case-control study from a tertiary care center in Turkey. Eur J Pediatr. 2015 Jun;174(6):809-15. doi: 10.1007/s00431-014-2469-1. Epub 2014 Dec 12.</citation>
    <PMID>25504199</PMID>
  </reference>
  <reference>
    <citation>Abrams SA; Committee on Nutrition. Calcium and vitamin d requirements of enterally fed preterm infants. Pediatrics. 2013 May;131(5):e1676-83. doi: 10.1542/peds.2013-0420. Epub 2013 Apr 29. Review.</citation>
    <PMID>23629620</PMID>
  </reference>
  <reference>
    <citation>Agostoni C, Buonocore G, Carnielli VP, De Curtis M, Darmaun D, Decsi T, Domellöf M, Embleton ND, Fusch C, Genzel-Boroviczeny O, Goulet O, Kalhan SC, Kolacek S, Koletzko B, Lapillonne A, Mihatsch W, Moreno L, Neu J, Poindexter B, Puntis J, Putet G, Rigo J, Riskin A, Salle B, Sauer P, Shamir R, Szajewska H, Thureen P, Turck D, van Goudoever JB, Ziegler EE; ESPGHAN Committee on Nutrition. Enteral nutrient supply for preterm infants: commentary from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition Committee on Nutrition. J Pediatr Gastroenterol Nutr. 2010 Jan;50(1):85-91. doi: 10.1097/MPG.0b013e3181adaee0.</citation>
    <PMID>19881390</PMID>
  </reference>
  <reference>
    <citation>Płudowski P, Karczmarewicz E, Bayer M, Carter G, Chlebna-Sokół D, Czech-Kowalska J, Dębski R, Decsi T, Dobrzańska A, Franek E, Głuszko P, Grant WB, Holick MF, Yankovskaya L, Konstantynowicz J, Książyk JB, Księżopolska-Orłowska K, Lewiński A, Litwin M, Lohner S, Lorenc RS, Lukaszkiewicz J, Marcinowska-Suchowierska E, Milewicz A, Misiorowski W, Nowicki M, Povoroznyuk V, Rozentryt P, Rudenka E, Shoenfeld Y, Socha P, Solnica B, Szalecki M, Tałałaj M, Varbiro S, Żmijewski MA. Practical guidelines for the supplementation of vitamin D and the treatment of deficits in Central Europe - recommended vitamin D intakes in the general population and groups at risk of vitamin D deficiency. Endokrynol Pol. 2013;64(4):319-27.</citation>
    <PMID>24002961</PMID>
  </reference>
  <reference>
    <citation>Monangi N, Slaughter JL, Dawodu A, Smith C, Akinbi HT. Vitamin D status of early preterm infants and the effects of vitamin D intake during hospital stay. Arch Dis Child Fetal Neonatal Ed. 2014 Mar;99(2):F166-8. doi: 10.1136/archdischild-2013-303999. Epub 2013 Jul 13.</citation>
    <PMID>23852093</PMID>
  </reference>
  <reference>
    <citation>Pinto K, Collins CT, Gibson RA, Andersen CC. Vitamin D in preterm infants: A prospective observational study. J Paediatr Child Health. 2015 Jul;51(7):679-81. doi: 10.1111/jpc.12847. Epub 2015 Feb 12.</citation>
    <PMID>25683497</PMID>
  </reference>
  <reference>
    <citation>Fort P, Salas AA, Nicola T, Craig CM, Carlo WA, Ambalavanan N. A Comparison of 3 Vitamin D Dosing Regimens in Extremely Preterm Infants: A Randomized Controlled Trial. J Pediatr. 2016 Jul;174:132-138.e1. doi: 10.1016/j.jpeds.2016.03.028. Epub 2016 Apr 11.</citation>
    <PMID>27079965</PMID>
  </reference>
  <reference>
    <citation>Backström MC, Kouri T, Kuusela AL, Sievänen H, Koivisto AM, Ikonen RS, Mäki M. Bone isoenzyme of serum alkaline phosphatase and serum inorganic phosphate in metabolic bone disease of prematurity. Acta Paediatr. 2000 Jul;89(7):867-73.</citation>
    <PMID>10943972</PMID>
  </reference>
  <reference>
    <citation>Nemet D, Dolfin T, Wolach B, Eliakim A. Quantitative ultrasound measurements of bone speed of sound in premature infants. Eur J Pediatr. 2001 Dec;160(12):736-40.</citation>
    <PMID>11795683</PMID>
  </reference>
  <reference>
    <citation>Rack B, Lochmüller EM, Janni W, Lipowsky G, Engelsberger I, Friese K, Küster H. Ultrasound for the assessment of bone quality in preterm and term infants. J Perinatol. 2012 Mar;32(3):218-26. doi: 10.1038/jp.2011.82. Epub 2011 Jun 16.</citation>
    <PMID>21681177</PMID>
  </reference>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 15, 2017</study_first_submitted>
  <study_first_submitted_qc>March 15, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 22, 2017</study_first_posted>
  <last_update_submitted>May 13, 2017</last_update_submitted>
  <last_update_submitted_qc>May 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 16, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Princess Anna Mazowiecka Hospital, Warsaw, Poland</investigator_affiliation>
    <investigator_full_name>Alicja Kołodziejczyk</investigator_full_name>
    <investigator_title>PhD student</investigator_title>
  </responsible_party>
  <keyword>vitamin D</keyword>
  <keyword>supplementation</keyword>
  <keyword>hydroxyvitamin D</keyword>
  <keyword>pretrem infants</keyword>
  <keyword>osteopenia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D Deficiency</mesh_term>
    <mesh_term>Bone Diseases, Metabolic</mesh_term>
    <mesh_term>Nephrolithiasis</mesh_term>
    <mesh_term>Kidney Calculi</mesh_term>
    <mesh_term>Drug Overdose</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

